Evidence map›Paper›PMID 35430327›Full record

ArticleEuropean journal of medical genetics2022

Novel biallelic variants affecting the OTU domain of the gene OTUD6B associate with severe intellectual disability syndrome and molecular dynamics simulations.

Sultan Cingöz, Didem Soydemir, Tülay Öncü Öner, Ezgi Karaca, Burcu Özden, Semra Hız Kurul, Erhan Bayram, University of Washington Center for Mendelian Genomics, Bradley P Coe, Deborah A Nickerson and 1 more

Open access · greenAbstract read
In one paragraph

Article in European journal of medical genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Sultan CingözDepartment of Medical Biology and Genetics, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey; Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA. Electronic address: sultan.cingoz@deu.edu.tr.
Didem SoydemirDepartment of Pediatrics, Division of Child Neurology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Tülay Öncü ÖnerDepartment of Medical Biology and Genetics, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Ezgi KaracaIzmir Biomedicine and Genome Center, Dokuz Eylul Health Campus, Izmir, Turkey; Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkey.
Burcu ÖzdenIzmir Biomedicine and Genome Center, Dokuz Eylul Health Campus, Izmir, Turkey; Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Turkey.
Semra Hız KurulDepartment of Pediatrics, Division of Child Neurology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey; Izmir Biomedicine and Genome Center, Dokuz Eylul Health Campus, Izmir, Turkey.
Erhan BayramDepartment of Pediatrics, Division of Child Neurology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
University of Washington Center for Mendelian GenomicsDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Bradley P CoeDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Deborah A NickersonDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Evan E EichlerDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA.
Dokuz Eylül University · TRIzmir University · TRUniversity of Washington · USHoward Hughes Medical Institute · US

Funding

UW Center for Mendelian GenomicsU54HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, NICKERSON, DEBORAH A · 2012 to 2015
$20.0M
University of Washington Mendelian Genomics Research Center (UW-MGRC)U01HG011744 · NHGRI · UNIVERSITY OF WASHINGTON · PI MICHAEL Joseph BAMSHAD, Evan Eichler · 2021 to 2026
$15.8M
UW Center for Mendelian GenomicsUM1HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, LEAL, SUZANNE M · 2016 to 2020
$15.3M
Sporadic Mutations and Autism Spectrum DisordersR01MH101221 · NIMH · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2025
$9.2M
NHGRI Genome Sequencing Program Coordinating CenterU24HG008956 · NHGRI · RUTGERS, THE STATE UNIV OF N.J. · PI BUYSKE, STEVEN G, MATISE, TARA C. · 2016 to 2020
$4.9M
NHGRI NIH HHS U01 HG011744NHGRI NIH HHS U24 HG008956NHGRI NIH HHS U54 HG006493NHGRI NIH HHS UM1 HG006493NIMH NIH HHS R01 MH101221
6 · The paper itself

Abstract

Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies (IDDFSDA) is an autosomal recessive multisystem disorder caused by compound heterozygous or homozygous variants in the gene OTUD6B. Herein, we describe novel pathogenic compound heterozygous variants in OTUD6B identified via whole-exome sequencing in an index case exhibited the severe IDDFSDA phenotype. The potential pathogenicity of the novel frameshift and missense variants in the index case was investigated using in silico tools. The truncating frameshift variant in one allele was predicted to undergo degradation via nonsense-mediated decay of the mRNA molecule. To predict the severity of the damage to the protein caused by the missense variant in the other allele and its effects on phenotypic severity was further investigated together with a previously reported first homozygous missense variant in the same domain in another patient with a less severe IDDFSDA phenotype using structural modeling and molecular dynamics (MD) simulations for the first time. Based on these analyzes, it is anticipated that Tyr216Cys in the earlier reported case with less severe IDDFSDA will lead to localized destabilization, whereas Ile274Arg in the presented index case with the severe IDDFSDA phenotype will lead to significant distortion in the overall fold of OTUD6B. Our findings suggest that compound LOF and ultrarare missense variants may be contribute to the underlying variability expressivity associated with this disorder. In conclusion, our findings support that the clinical severity could be related with the predicted functional severity of the variations in OTUD6B. However, additional functional studies are required.

Indexed as

EndopeptidasesIntellectual DisabilityExome SequencingHomozygoteHumansMolecular Dynamics SimulationPhenotypeEndopeptidasesOTUD6B protein, humanMissense variantMolecular dynamics simulationsOTUD6BOTU domainSevere IDDFSDA

Identifiers

PMID35430327
PMCPMC9448893
OpenAlexW4224123109

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.